Invesco Ltd. Guardant Health, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 2,902,074 shares of GH stock, worth $89 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,902,074

Previous 1,207,469 140.34%

Holding current value

$89 Million

Previous $34.9 Million 90.83%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$22.3 - $36.29 $37.8 Million - $61.5 Million	1,694,605 Added 140.34%	2,902,074 $66.5 Million
Q2 2024 Aug 13, 2024	SELL	$16.07 - $31.84 $2.04 Million - $4.04 Million	-126,801 Reduced 9.5%	1,207,469 $34.9 Million
Q1 2024 May 14, 2024	BUY	$17.13 - $26.91 $4.19 Million - $6.58 Million	244,628 Added 22.45%	1,334,270 $27.5 Million
Q4 2023 Feb 12, 2024	BUY	$21.58 - $29.5 $420,594 - $574,955	19,490 Added 1.82%	1,089,642 $29.5 Million
Q3 2023 Nov 13, 2023	BUY	$25.8 - $39.97 $4.63 Million - $7.18 Million	179,593 Added 20.17%	1,070,152 $31.7 Million
Q2 2023 Aug 11, 2023	SELL	$20.94 - $38.01 $26.4 Million - $48 Million	-1,262,967 Reduced 58.65%	890,559 $31.9 Million
Q1 2023 May 12, 2023	BUY	$22.92 - $33.76 $29.4 Million - $43.3 Million	1,283,502 Added 147.52%	2,153,526 $50.5 Million
Q4 2022 Feb 13, 2023	BUY	$25.44 - $59.78 $6.16 Million - $14.5 Million	242,217 Added 38.58%	870,024 $23.7 Million
Q3 2022 Nov 14, 2022	BUY	$43.66 - $61.0 $20.8 Million - $29 Million	475,745 Added 312.86%	627,807 $33.8 Million
Q2 2022 Aug 15, 2022	BUY	$28.82 - $77.35 $164,591 - $441,745	5,711 Added 3.9%	152,062 $6.14 Million
Q1 2022 May 16, 2022	SELL	$48.25 - $100.49 $1.42 Million - $2.95 Million	-29,355 Reduced 16.71%	146,351 $9.69 Million
Q4 2021 Feb 14, 2022	SELL	$88.71 - $120.43 $65.8 Million - $89.3 Million	-741,369 Reduced 80.84%	175,706 $17.6 Million
Q3 2021 Nov 15, 2021	BUY	$98.77 - $132.17 $5.39 Million - $7.21 Million	54,549 Added 6.32%	917,075 $115 Million
Q2 2021 Aug 17, 2021	SELL	$109.77 - $165.68 $7.1 Million - $10.7 Million	-64,692 Reduced 6.98%	862,526 $107 Million
Q1 2021 May 17, 2021	BUY	$127.04 - $179.1 $67.3 Million - $94.9 Million	529,671 Added 133.23%	927,218 $142 Million
Q4 2020 Feb 16, 2021	BUY	$99.96 - $135.93 $23.8 Million - $32.4 Million	238,216 Added 149.51%	397,547 $51.2 Million
Q3 2020 Nov 16, 2020	SELL	$80.32 - $111.8 $4.67 Million - $6.5 Million	-58,099 Reduced 26.72%	159,331 $17.8 Million
Q2 2020 Aug 14, 2020	BUY	$60.49 - $97.5 $216,856 - $349,537	3,585 Added 1.68%	217,430 $17.6 Million
Q1 2020 May 15, 2020	BUY	$59.04 - $88.81 $387,597 - $583,037	6,565 Added 3.17%	213,845 $14.9 Million
Q4 2019 Feb 14, 2020	BUY	$59.49 - $82.78 $125,583 - $174,748	2,111 Added 1.03%	207,280 $16.2 Million
Q3 2019 Nov 14, 2019	BUY	$62.59 - $110.3 $1.21 Million - $2.14 Million	19,396 Added 10.44%	205,169 $13.1 Million
Q2 2019 Aug 14, 2019	BUY	$63.94 - $91.11 $8.27 Million - $11.8 Million	129,343 Added 229.21%	185,773 $16 Million
Q1 2019 May 15, 2019	BUY	$34.3 - $97.98 $1.94 Million - $5.53 Million	56,430 New	56,430 $4.33 Million

Others Institutions Holding GH

# of Institutions

323

Shares Held

127M

Call Options Held

844K

Put Options Held

2.38M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.14B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account